Evidence-Based Medicine Guidelines
Cyclin-dependent kinase inhibitor for advanced breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cyclin-dependent Kinase Inhibitor for Advanced Breast Cancer." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305408/all/_________Cyclin_dependent_kinase_inhibitor_for_advanced_breast_cancer______.
Cyclin-dependent kinase inhibitor for advanced breast cancer. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305408/all/_________Cyclin_dependent_kinase_inhibitor_for_advanced_breast_cancer______. Accessed April 30, 2025.
Cyclin-dependent kinase inhibitor for advanced breast cancer. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305408/all/_________Cyclin_dependent_kinase_inhibitor_for_advanced_breast_cancer______
Cyclin-dependent Kinase Inhibitor for Advanced Breast Cancer [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305408/all/_________Cyclin_dependent_kinase_inhibitor_for_advanced_breast_cancer______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cyclin-dependent kinase inhibitor for advanced breast cancer
ID - 1305408
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305408/all/_________Cyclin_dependent_kinase_inhibitor_for_advanced_breast_cancer______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
